Announce Date | 05/20/2025 |
EPS Normalized Actual | $0.37 (Miss by $-2.41) |
EPS GAAP Actual | $0.37 (Miss by $-2.41) |
Revenue Actual | $10.8915B |
Revenue Surprise | Beat by $10891.5M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $3.6155 |
EPS GAAP Estimate | $3.6155 |
Revenue Estimate | $1.687511297B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 13.97466 | 1.34 | 12.9096 | 15.37285 | 1 |
Dec 2026 | 14.72585 | 1.27 | 12.12 | 16.19848 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.5 | -0.50951 | 10.8915B | 8.55% | 9394.69M |
FQ4 2024 (Dec 2024) | 2.89 | -0.63282 | 12.9197B | 17.8% | 11163.54M |
FQ3 2024 (Sep 2024) | 0 | -1.54141 | 10.675B | 14.98% | -11240.73M |
FQ2 2024 (Jun 2024) | 0.45 | -0.89259 | 10.726B | 9.19% | -8754.65M |
FQ1 2015 (Mar 2015) | 0.35 | 0.35 | 1.24303B | 100% | 1243.03M |
FQ2 2015 (Jun 2015) | 0.35 | 0.35 | 1.24303B | 100% | 1243.03M |
FQ1 2024 (Mar 2024) | 1.77 | 0.94 | 9.96001B | 9.81% | 5383.58M |
FQ4 2023 (Dec 2023) | 2.66 | 2.66 | 10.6194B | 7.04% | 10619.4M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
3.6155
Consensus Revenue Estimates
1.687511297B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.49019 | -- | 3.37991 | 3.5561 | 1 |
FQ2 2027 (Jun 2027) | 3.60879 | -- | 3.49476 | 3.67694 | 1 |
FQ1 2027 (Mar 2027) | 3.86561 | -- | 3.74347 | 3.93861 | 1 |
FQ4 2026 (Dec 2026) | 4.21961 | -- | 4.14213 | 4.27224 | 0 |
FQ3 2026 (Sep 2026) | 3.7569 | -- | 3.68791 | 3.80375 | 0 |
FQ2 2026 (Jun 2026) | 4.35388 | -- | 4.27393 | 4.40818 | 0 |
FQ1 2026 (Mar 2026) | 2.96645 | 15.72 | 2.91198 | 3.00345 | 0 |
FQ4 2025 (Dec 2025) | 4.36732 | 33.83 | 4.11907 | 4.65138 | 1 |
FQ3 2025 (Sep 2025) | 3.6155 | -- | 3.40998 | 3.85066 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 16.4B | -- | 16B | 16.64B | 2 |
FQ2 2027 (Jun 2027) | 15.77B | -- | 15.39B | 16B | 2 |
FQ1 2027 (Mar 2027) | 15.43B | -- | 15.05B | 15.65B | 1 |
FQ4 2026 (Dec 2026) | 2.03B | -- | 2.01B | 2.05B | 1 |
FQ3 2026 (Sep 2026) | 1.78B | -- | 1.75B | 1.8B | 1 |
FQ2 2026 (Jun 2026) | 1.85B | -- | 1.83B | 1.87B | 1 |
FQ1 2026 (Mar 2026) | 1.53B | -610.45 | 1.51B | 1.55B | 1 |
FQ4 2025 (Dec 2025) | 2B | -544.55 | 1.92B | 2.1B | 0 |
FQ3 2025 (Sep 2025) | 1.69B | -532.59 | 1.61B | 1.77B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.00951 | 2.5 | -0.50951 | -20.38% |
FQ4 2024 (Dec 2024) | 3.52282 | 2.89 | -0.63282 | -21.9% |
FQ3 2024 (Sep 2024) | 1.54141 | 0 | -1.54141 | -INF% |
FQ2 2024 (Jun 2024) | 1.34259 | 0.45 | -0.89259 | -198.35% |
FQ1 2015 (Mar 2015) | 0.35 | 0.35 | 100% | |
FQ2 2015 (Jun 2015) | 0.35 | 0.35 | 100% | |
FQ1 2024 (Mar 2024) | 0.83 | 1.77 | 0.94 | 53.11% |
FQ4 2023 (Dec 2023) | 2.66 | 2.66 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.5B | $10.89B | $9394.69M | 86.26% |
FQ4 2024 (Dec 2024) | $1.76B | $12.92B | $11163.54M | 86.41% |
FQ3 2024 (Sep 2024) | $21.92B | $10.68B | $-11240.73M | -105.3% |
FQ2 2024 (Jun 2024) | $19.48B | $10.73B | $-8754.65M | -81.62% |
FQ1 2015 (Mar 2015) | $0B | $1.24B | $1243.03M | 100% |
FQ2 2015 (Jun 2015) | $0B | $1.24B | $1243.03M | 100% |
FQ1 2024 (Mar 2024) | $4.58B | $9.96B | $5383.58M | 54.05% |
FQ4 2023 (Dec 2023) | $0B | $10.62B | $10619.4M | 100% |